In vitro‐Digested Cervus nippon Velvet Antler Polypeptides Alleviate Alcoholic Liver Disease by Suppressing CYP2E1 Activity and Enhancing AMPK Signaling Pathway

Deer antler velvet (DAV), historically documented in Shennong's Classic of Materia Medica, is traditionally valued as a functional food believed to promote liver and kidney health and to strengthen the musculoskeletal system. Modern research highlights the bioactivity of sika deer (Cervus nippon Temminck) velvet antler peptides (sVAP), though their potential against alcoholic liver disease (ALD) remains unclear. This study aims to prepare sVAP through in vitro digestion and systematically evaluate their potential protective effects against ALD, while further elucidating the underlying mechanisms of action. Our findings demonstrate that the 1-3 kDa fraction (sVAP-1-3 kDa) exhibited the strongest hepatoprotection, reducing alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), and malondialdehyde (MDA) while enhancing superoxide dismutase (SOD) and glutathione (GSH). It alleviated reactive oxygen species (ROS) accumulation, suppressed apoptosis and lipid deposition, and activated nuclear factor erythroid 2-related factor 2 (Nrf2) signaling. Network pharmacology predicted 430 targets enriched in cytochrome P450 metabolism, lipid regulation, and inflammation. Docking showed strong binding of CYP2E1 to peptide motifs such as DFGFDGD, YFPH, FPAVP, and TYFPH. Western blotting confirmed that sVAP-1-3 kDa modulated CYP2E1/Nrf2/HO-1 and AMPK pathways, downregulating CYP2E1, SREBP-1c, FAS and PPARγ while upregulating Nrf2, HO-1, p-AMPKα. This study employed simulated in vitro digestion to prepare sVAP first. sVAP-1-3 kDa exerts antioxidative and anti-lipogenic effects, thereby attenuating oxidative stress, lipid synthesis, and ALD progression, providing pharmacological evidence for the traditional use of DAV. PRACTICAL APPLICATIONS: Polypeptides extracted from antler velvet, a substance with both medicinal and dietary value, have been shown to exert therapeutic effects against alcoholic liver disease and may serve as promising candidates for the development of functional foods beneficial to individuals with excessive alcohol consumption.

Authors

Institutions

Publication Details

Journal
Journal of Food Science
Published
2025-11-30
DOI
https://doi.org/10.1111/1750-3841.70711
Primary Topic
Alcohol Consumption and Health Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vitro‐Digested Cervus nippon Velvet Antler Polypeptides Alleviate Alcoholic Liver Disease by Suppressing CYP2E1 Activity and Enhancing AMPK Signaling Pathway

Hongbo Yang, Yuling Ding, Yuli Yan, Ye Wang et al.
Journal of Food Science
Alcohol Consumption and Health Effects
article

In vitro‐Digested Cervus nippon Velvet Antler Polypeptides Alleviate Alcoholic Liver Disease by Suppressing CYP2E1 Activity and Enhancing AMPK Signaling Pathway

Hongbo Yang, Yuling Ding, Yuli Yan, Ye Wang, Ce Zhang, Yihua Wang, Yong Li, Xiaowei Huang, Zezhuang Hao
article en

Abstract

Deer antler velvet (DAV), historically documented in Shennong's Classic of Materia Medica, is traditionally valued as a functional food believed to promote liver and kidney health and to strengthen the musculoskeletal system. Modern research highlights the bioactivity of sika deer (Cervus nippon Temminck) velvet antler peptides (sVAP), though their potential against alcoholic liver disease (ALD) remains unclear. This study aims to prepare sVAP through in vitro digestion and systematically evaluate their potential protective effects against ALD, while further elucidating the underlying mechanisms of action. Our findings demonstrate that the 1-3 kDa fraction (sVAP-1-3 kDa) exhibited the strongest hepatoprotection, reducing alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), and malondialdehyde (MDA) while enhancing superoxide dismutase (SOD) and glutathione (GSH). It alleviated reactive oxygen species (ROS) accumulation, suppressed apoptosis and lipid deposition, and activated nuclear factor erythroid 2-related factor 2 (Nrf2) signaling. Network pharmacology predicted 430 targets enriched in cytochrome P450 metabolism, lipid regulation, and inflammation. Docking showed strong binding of CYP2E1 to peptide motifs such as DFGFDGD, YFPH, FPAVP, and TYFPH. Western blotting confirmed that sVAP-1-3 kDa modulated CYP2E1/Nrf2/HO-1 and AMPK pathways, downregulating CYP2E1, SREBP-1c, FAS and PPARγ while upregulating Nrf2, HO-1, p-AMPKα. This study employed simulated in vitro digestion to prepare sVAP first. sVAP-1-3 kDa exerts antioxidative and anti-lipogenic effects, thereby attenuating oxidative stress, lipid synthesis, and ALD progression, providing pharmacological evidence for the traditional use of DAV. PRACTICAL APPLICATIONS: Polypeptides extracted from antler velvet, a substance with both medicinal and dietary value, have been shown to exert therapeutic effects against alcoholic liver disease and may serve as promising candidates for the development of functional foods beneficial to individuals with excessive alcohol consumption.

Journal of Food ScienceVol. 90(12)
Changchun University of Chinese Medicine (CN)
Openalex Percentile: Top 48%
Alcohol Consumption and Health Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.